Shirley L. Steiner Joins InClinica as Senior Global Clinical Operations Director
PHILADELPHIA (December 15, 2017) – InClinica, a global clinical CRO, announced that Shirley L. Steiner has been appointed Senior Global Clinical Operations Director. Steiner will be responsible for directly overseeing the development and execution of global clinical trials.
Steiner has more than 20 years of experience in the pharmaceutical industry, with extensive knowledge of Good Clinical Practice and ICH guidelines. She is well-versed in a variety of global clinical research programs including vascular, cardiovascular, coagulation, thrombosis, immunology, internal medicine, oncology, rare disease and devices. Before joining InClinica, Steiner served as Director of Clinical Operations for BTG International Inc.
“We are thrilled to welcome Shirley to the InClinica team,” said Dani Bradbury, VP General Manager at InClinica. “Her deep experience in global clinical trial implementation and clinical research will be exceptionally valuable in ensuring we are supporting some of the most successful trials in the field.”
Steiner holds a B.S. in Cell and Molecular Biology from The University of Michigan.
InClinica is a global clinical contract research organization founded in 2016 after the acquisition of an existing global CRO. With a senior management team that brings more than 100 combined years of experience, InClinica works across all phases of the clinical research process and has a particular strength in first in man and phase 2 studies. InClinica is headquartered in Philadelphia with other locations in the U.K., Israel, and Malaysia/Singapore.